Phase 3 pivotal trial in AFib-RVR expected to begin enrollment in H1 ... Important factors that could cause actual results to differ materially from those in the forward-looking statements include ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib-RVR. It is designed as a self-administered rapid ...